|
ИСТИНА |
Войти в систему Регистрация |
Интеллектуальная Система Тематического Исследования НАукометрических данных |
||
Multiresponsive Hybrid Microparticles for Stimuli-Responsive Delivery of Bioactive Compoundsстатья
- Авторы: Vlasov Sergei S., Postnikov Pavel S., Belousov Mikhail V., Krivoshchekov Sergei V., Yusubov Mekhman S., Guryev Artem M., Martino Antonio Di
- Журнал: Applied Sciences
- Том: 10
- Номер: 12
- Год издания: 2020
- Издательство: Universitatea Politehnica Bucuresti
- Местоположение издательства: Romania
- Номер статьи: 4324
- DOI: 10.3390/app10124324
- Аннотация: Hybrid microparticles based on an iron core and an amphiphilic polymeric shell have been prepared to respond simultaneously to magnetic and ultrasonic fields and variation in the surrounding pH to trigger and modulate the delivery of doxorubicin. The microparticles have been developed in four steps: (i) synthesis of the iron core; (ii) surface modification of the core; (iii) conjugation with the amphiphilic poly(lactic acid)-grafted chitosan; and (iv) doxorubicin loading. The particles demonstrate spherical shape, a size in the range of 1–3 µm and surface charge that is tuneable by changing the pH of the environment. The microparticles demonstrate good stability in simulated physiological solutions and are able to hold up to 400 µg of doxorubicin per mg of dried particles. The response to ultrasound and the changes in the shell structure during exposure to different pH levels allows the control of the burst intensity and release rate of the payload. Additionally, the magnetic response of the iron core is preserved despite the polymer coat. In vitro cytotoxicity tests performed on fibroblast NIH/3T3 demonstrate a reduction in the cell viability after administration of doxorubicin-loaded microparticles compared to the administration of free doxorubicin. The application of ultrasound causes a burst in the release of the doxorubicin from the carrier, causing a decrease in cell viability. The microparticles demonstrate in vitro cytocompatibility and hemocompatibility at concentrations of up to 50 and 60 µg/mL,
- Добавил в систему: Юсубов Мехман Сулейман оглы